Intuitive Surgical sees slower 2017 procedure growth, buys back shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Canaccord Genuity Reiterates Buy on Intuitive Surgical (ISRG) Following 4Q Report
January 25, 2017 9:35 AM ESTCanaccord Genuity reiterated a Buy rating and $800.00 price target on Intuitive Surgical (NASDAQ: ISRG) following the company's 4Q earnings report. Management reiterated expectations for 2017 procedure growth in the range of 9-12%. The company also issued first-time pro forma GM guidance, projecting gross margins in the range of 69-71%.
Analyst Jason Mills commented, "ISRG is shaping up to be one of the most compelling large-cap med-tech stocks in the sector, in our view; thus, we stay buyers of the stock. Coming... More
